跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PAPAVERINE PHEBRA papaverine hydrochloride 120 mg/10 mL solution for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
PAPAVERINE PHEBRA papaverine hydrochloride 120 mg/10 mL solution for injection vial
Approved
STANDARD
PAPAVERINE PHEBRA papaverine hydrochloride 120 mg/10 mL solution for injection vial
Phebra Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
6caee7e98c027bdd
Company
Phebra Pty Ltd
Type
Standard
Approval Details
Approval Id
6caee7e98c027bdd
Product Name
PAPAVERINE PHEBRA papaverine hydrochloride 120 mg/10 mL solution for injection vial
Artg Id
462225
Artg Name
PAPAVERINE PHEBRA papaverine hydrochloride 120 mg/10 mL solution for injection vial
Sponsor
Phebra Pty Ltd
Company Detail Path
/organization/phebra-pty-ltd
Artg Date
2025-08-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
6caee7e98c027bdd
Type
Standard
Back to TGA Approvals